Atlas Trials

A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects

Clinical trial NCT07357831 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07357831
Sponsor
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Plaque Psoriasis
Start date
2025-12-26
Primary completion
2026-10-10
Enrollment
537

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.